As of Oct 17
| +0.01 / +0.21%|
The 8 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 11.50, with a high estimate of 32.00 and a low estimate of 6.00. The median estimate represents a +136.63% increase from the last price of 4.86.
The current consensus among 8 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.